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Nef proteins of primate immunodeficiency viruses exert pleiotropic effects, such as enhanced endocytosis of CD4 and
MHC-I cell surface molecules, perturbation of signal transduction cascades, and virion infectivity enhancement. Nef function
intersects that of a number of cell kinases, including C kinases (PKCs) and Src-family kinases. Here the interaction of HIV-1
Nef with Rack1 (receptor for activated C kinase 1) is reported. Nef binds the Rack1 C-terminal moiety in a yeast two-hybrid
system and in cell-free pull-down assays and copurifies with in vitro translated Rack1. Nef and Rack1 partially colocalize on
the trans-Golgi network and plasma membranes. The presence of Rack1 doubles Nef phosphorylation by PKCs in vitro. Our
data agree with the idea that Rack1 acts as a Nef intracellular docking site, bringing Nef and PKCs together. Other signal
transduction or endocytosis proteins, in particular Src-like kinases, might meet Nef by intermediation of the Rack1 adaptor.
© 2001 Academic Press
eINTRODUCTION
Nef proteins are encoded by a gene overlapping the 39
long terminal repeats of human immunodeficiency vi-
ruses, types 1 and 2 (HIV-1 and -2), and simian immuno-
deficiency virus (SIV). Nef is synthesized early after in-
fection and is crucial for the maintenance of high viral
loads and for pathogenesis (recent reviews in Cullen,
1998; Marsh, 1999; Oldridge and Marsh, 1998; Harris,
1999). The replication advantage of Nef-positive viruses
may be due in part to the enhancement of viral particle
infectivity (Aiken and Trono, 1995; Chowers et al., 1995;
Miller et al., 1994; Le Gall et al., 1997) and/or virion
release (Lama et al., 1999; Ross et al., 1999), in part to
Nef-induced release by infected macrophages of CC-
chemokines recruiting and activating CD41 lymphocytes
at sites of virus replication (Swingler et al., 1999). How-
ever, Nef exerts direct pathogenic effects in the absence
of other viral products, as shown by the occurrence of an
AIDS-like impairment of the immune system in mice
expressing a nef transgene (Skowronski et al., 1993;
Hanna et al., 1998; Larsen et al., 1998).
Nef has been credited with diverse molecular partner-
ships inside the infected cell. One of Nef’s roles is to
decrease the cell surface expression of CD4 (and less
efficiently of HLA-A/B) by accelerating CD4 endocytosis
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Fax: 139-(0)382-422286. E-mail: milanesi@igbe.pv.cnr.it.
7and routing receptors to lysosomes for degradation. Nef
may function as a connector linking CD4 to endocytic
adaptor complexes [to the endocytic signals within CD4
and MHC-I cytoplasmic tails; to b/m adaptins in clathrin
adaptor complexes; to PACS-1 in the trans-Golgi network
(TGN) (Piguet et al., 2000); to b-COP in coatomer-coated
vesicles in the TGN to the lysosome route], although
exploiting distinct interaction surfaces in HIV-1 Nef and
the cognate SIV protein (reviewed in Piguet et al., 1999;
Oldridge and Marsh, 1998). Since a mutated CD4 cyto-
plasmic tail lacking protein kinase C (PKC) target-serines
has been shown to be refractory to phorbol esters but
sensitive to Nef downregulation (Garcia and Miller, 1991;
Aiken et al., 1994), the CD4 endocytosis induced by Nef
seems to be independent of CD4 phosphorylation. Con-
versely, Nef phosphorylation by phorbol-ester-activated
PKC enhances the Nef-promoted downregulation of CD4
(Luo et al., 1997). Also, Nef has been proposed to bind
theta PKC, an isozyme important for T-cell activation, and
to inhibit its function (Smith et al., 1996). Nef is, in addi-
tion, a nonsubstrate ligand for various serine/threonine
and nonreceptor tyrosine kinases (reviewed in Renkema
and Saksela, 2000). Among the latter, Nef interacts with
Lck, Hck, and Src kinases, with an essential role in the
association played by Nef polyproline helix II binding
kinase SH3 domain. Perturbations of the normal func-
tioning of CD4, T-cell receptor, and signaling kinases
(Bell et al., 1998; Howe et al., 1998; Fackler et al., 1999; Xu
t al., 1999; Wang et al., 2000) most probably underly the
reported alterations in cell signaling pathways and gene
expression induced by Nef.These multiple Nef effects reflect the activities of a
truly multifunctional viral protein, since they are partly
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8 GALLINA, ROSSI, AND MILANESImutationally separable (Goldsmith et al., 1995; Le Gall et
al., 1997; Iafrate et al., 1997; Mangasarian et al., 1999).
lso, the growing number of molecular interactions that
re being reported for Nef seemingly reflect the ability of
he viral protein to insert into, and modify, the network of
ynamic interactions taking place in the endosomal
athway and in signal transduction cascades. Here, we
how that HIV-1 Nef can associate with Rack1 (receptor
or activated C kinase 1), a known intracellular receptor
or PKCs and other C2 domain-containing proteins (Ron
t al., 1994). We also show that Rack1 is, like Nef, in
quilibrium between a cytosolic and a membrane-bound
tate and that it partially colocalizes with the viral protein
FIG. 1. Summary of Y2HS constructs implicating Rack1 as a Nef part
corresponding linear representation of Rack1 WD40 repeats (right, top)
of the truncated Rack1 cDNAs recovered in the Y2HS screen describ
selected in Y2HS screening; A-, Gal4 activation domain. Secondary st
ach WD40 module includes the four b-sheets d, a, b, and c (Wall e
indicates that each d b-sheet is structurally associated with the a–c s
he first WD40 stacks with the c element of the seventh WD40, assurin
f the protein and shaping it into a seven-blade propeller (Wall et al.
triangles, b-sheets; myr-Gly, myristic acid adduct conjugated to Nef glntracellularly. Interestingly, Rack1 enhances Nef phos-
horylation by PKCs in vitro.RESULTS AND DISCUSSION
A yeast two-hybrid system (Y2HS) screening, in which
IV-1 Nef was used as a bait for a human cDNA library
rom HeLa cells (Rossi et al., 1997), identified partial
DNAs for Rack1 as recurrent prey inserts (five indepen-
ent clones; Fig. 1A). Previous studies exploiting similar
east screenings have led to the identification of the
oatomer component b-COP (Benichou et al., 1994), of a
hioesterase (Liu et al., 1997; Watanabe et al., 1997), of
the HsN3 proteasome subunit (Rossi et al., 1997), of a
subunit of the vacuolar proton ATPase involved in endo-
some acidification (Lu et al., 1998), and of Naf, a putative
Rack1 predicted structure from homology to Gb polypeptide (left); the
HS Gal4–Rack1 hybrid proteins (right, bottom). Arrows signal the start
e. The hybrid A–Rack5–7 is the product of the original clone (No. 5)
representation follows the TOPS conventions (Westhead et al., 1999).
995). Circular permutation in the WD40 secondary structure lettering
f the preceding WD40 repeat, forming a blade. The d sheet ahead of
o-called “velcro” closure between the N-terminus and the C-terminus
(B) Top: Schematic representation of Nef protein. Circles, a-helices;
. Bottom: Gal4–Nef hybrid proteins. DB, Gal4 DNA-binding domain.ner. (A)
, and Y2
ed her
ructure
t al., 1
heets o
g the sCD4 escort (Fukushi et al., 1999) as Nef partners.
All of the Rack1 clones were terminally sequenced
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9Rack1 BINDS HIV-1 Nefand found to cover the 39 3/7th of Rack1 coding se-
quence (codons 160/180 through 317). The shortest clone
was totally sequenced and found to exactly match the
published nucleotide sequence of the human gene. Hu-
man Rack1 was originally identified as a homolog of
heterotrimeric G–protein b subunits (Guillemot et al.,
1989). Like these, Rack1 contains seven tandem repeti-
tions of the WD40 domain (Neer et al., 1994), each in-
cluding four b strands, and is expected to fold into a
toroidal, seven-bladed b propeller structure (Neer and
Smith, 1996; Fig. 1A). In resolved structures, propeller
stabilization is provided by a “velcro” closure between the
N-terminal-most and the C-terminal-most b strands,
ithin the first and seventh WD40 repeat, respectively,
nd repeats are permuted with respect to the structural
epeats (blades) of the b propeller domain (Wall et al.,
1995; Fig. 1A). Rack1 lacks the N-terminal a-helical ex-
tension essential for G–b interaction with the gamma
subunits (Wall et al., 1995). From this background, the
reliminary inference could be made that Nef binding by
ack1 relies on the C-terminal WD40 repeats 5–7, since
he shortest ths Rack1 cDNA clone exactly covers these
epeats, and that a complete, circularized Rack1 propel-
er structure is not essential for Nef binding.
We consequently set up experiments aimed at ad-
ressing the following questions: (i) whether spurious
FIG. 2. Y2HS tests. HF7c yeast cells were transformed with plasmid
ynthetic medium-agar plates, lacking the selection amino acids (Trp a
fter 4 days at 30°C, triple selective plates were inspected for colony
ctivity. Alternatively, single colonies were reinoculated into liquid SD-s
rotein extraction according to the vortexing-glass beads method. Tota
in liquid. b-Gal activity values (average of at least three colonies from
positive control [the activity in cells harboring reference partners, the i
(amino acids 84–708)].ctivation of the ths reporters by Rack1 C-terminal moiety
ould be ruled out; (ii) whether the interaction could be
s
peproduced in cell-free assays; and (iii) which tracts
ithin Rack1 and Nef were critical for the interaction.
For Y2HS false interaction exclusion, the original Y2HS
ack1(WD5–7) insert within the Gal4-activation domain
AD) plasmid was transformed alone or cotransformed
ith plasmids expressing the Gal4 DNA-binding domain
DB) either unfused or fused to a Nef-unrelated protein.
The absence of Y2HS activation by Gal4–DB–Nef alone,
r crossed with control Gal4–AD constructs, had been
reviously shown by our and other laboratories). None of
he control crosses significantly activated the yeast re-
orters, thus reassuring us as to the specificity of the
ack1–Nef interaction (Fig. 2).
In order to confirm Rack1–Nef interaction in vitro, a
ecombinant hexahistidine-tagged Nef purified from bac-
erial cells or a Nef-unrelated control were pulled down
ith either Rack1(WD5–7) fused to glutathione S-trans-
erase (GST) or controls (GST alone or fused to a Nef-
nrelated protein). In agreement with the expectations
or a specific Rack1–Nef interaction, only the GST–
ack1(WD5–7) fusion efficiently captured recombinant
ef (Fig. 3A), while none of the GST variants appreciably
ulled down the Nef-unrelated control (hepatitis B virus
reS domain; not shown).
The above result further corroborated the view that
ack1(WD5–7) and Nef can physically interact. However,
inations to express the indicated proteins. Cells were plated onto SD
for double transformants, Trp, Leu, and His to select for Gal4 activity).
. Colonies from double selection plates were filter assayed for b-gal
n medium and shaken at 30°C overnight. Cells were lysed for soluble
n was assayed with the BCA reagent (Pierce) and b-gal was assayed
t two independent transformations) are expressed as a percentage of
ing hybrids Gal4–DB/p53 (amino acids 72–390) and Gal4–A/SV40 TAgcomb
nd Leu
growth
electio
l protei
at leasince Rack1(WD5–7) is not expected to fold into a closed
ropeller structure in the absence of WD40 repeats 1–4,
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10 GALLINA, ROSSI, AND MILANESIit was interesting to verify that a complete, folded Rack1
protein could also interact with Nef and that the ob-
served interaction was not due to the incorrect exposure
of amino acid residues normally hidden inside the folded
torus. To this purpose, we took advantage of the ability of
WD40 proteins to correctly fold when translated in vitro in
a rabbit reticulocyte lysate. Folded Rack1 polypeptides
produced in this system can be discriminated from in-
complete and/or misfolded molecules by gel filtration,
since the latter aggregate into high-molecular-weight
complexes (Garcia-Higuera et al., 1996). A coupled in
vitro transcription–translation system was programmed
with a plasmid expressing a full-length rat Rack1 (rat
Rack1 is identical at the amino acid level with the cog-
nate human protein; Ron et al., 1994). After completion of
the translation reaction, bacterial Nef was added and the
mixture was further incubated. The mixture was then
loaded onto an analytical gel filtration column and the
elution profile of recombinant Rack1 and Nef was re-
vealed by phosphorimaging or by Western blot, respec-
tively, after resolving proteins by SDS–PAGE. Results
showed that a proportion of in vitro translated Rack1, as
expected, aggregated and was excluded from the col-
umn. However, a fraction migrated as a folded monomer
and another minor fraction was resolved as a higher
molecular weight peak. Nef, on the other hand, eluted
mainly as a monomer, but a minor fraction was found to
FIG. 3. Rack1–Nef in vitro interactions. (A) Recombinant Rack1 C-term
as incubated with 10 ng of recombinant Nef, and the pulled-down co
r by SDS–PAGE and Coomassie staining (bottom), as described unde
human Plk1 kinase C-terminal domain (Gallina et al., 1999); pd, pulled-d
een captured. (B) In vitro translated, [35S]methionine-labeled Rack1 wa
loaded onto a Sephacryl 100 gel filtration column. The collected fracti
blotted, and analyzed by Western blotting with anti-Nef MAb; gel filtratio
before antibody incubations; V0, excluded volume, BSA, bovine serum
phosphorimager screen (Phosphorimager 445 SI, Molecular Dynamics
(fl) is shown.coelute with the higher molecular weight Rack1 peak
(Fig. 3B). When the addition of Nef to the Rack1 transla-
f
btion mixture was omitted, the Rack1 heavy peak disap-
peared; in contrast, on the same column neither Nef run
alone (in the presence of molecular weight markers) nor
Nef mixed with in vitro translated human G-alphai pro-
uced the higher molecular weight peak (data not
hown). We interpret these results as an indication that a
olded Rack1 and Nef can interact in vitro, forming a
eterodimer or higher order oligomer, which is chro-
atographically resolved from the monomeric forms of
ither protein.
We subsequently attempted to more extensively map
ack1–Nef interactions by use of the Y2HS assays (Fig.
). At first we asked whether Rack1 WD40 repeats 1–4,
lthough not necessary for the interaction, nonetheless
ould contribute to it, by either establishing additional
ontacts with the Nef molecule or stabilizing the C-
erminal WD40 repeats in the optimal fold. The full-length
at Rack1 or the N-terminal moiety spanning WD40 re-
eats 1–4 [Rack1(WD1–4)] was expressed in the reporter
east strain as Gal4–AD fusions, together with Gal4–DB–
ef. While Rack1(WD1–4) did not appreciably activate
east reporters, full-length Rack1 did, although to a sig-
ificantly lesser extent than Rack1(WD5–7). This sug-
ests that the WD40 repeats 1–4 do not contribute to Nef
inding. Nef binding by the full-length protein, on the
ther hand, confirms the in vitro results. The apparent
eduction in yeast reporter activation observed for the
main binds Nef in vitro. Five micrograms of the indicated GST fusions
es were analyzed either in Western blot with anti-Nef antibodies (top)
rials and Methods. GST–UP: GST fused to a Rack1-unrelated protein
uantification of the autoradiogram estimates that ’1/6th input Nef has
ated with purified molecular weight markers and recombinant Nef and
ction numbers indicated above the top panel) were electrophoresed,
er position was determined by Ponceau red staining of the membrane
min, Lys, chicken lysozyme. The membrane was next exposed to a
ioactive Rack1 band detection. The position of the full-length proteinsinal do
mplex
r Mate
own. Q
s incub
ons (fra
n mark
albuull-length relative to the truncated Rack1(WD5–7) may
e a consequence of the experimental setting; for in-
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11Rack1 BINDS HIV-1 Nefstance, the complete Rack1 may contain subcellular tar-
geting signals (membrane targeting signals; see below)
which counter the nuclear targeting needed for the ge-
netic assay to work; or, due to Rack1 circularization, the
N-terminally fused Gal4–A domain may create a steric
hindrance on the C-terminal blades, thus partially inhib-
iting Nef binding. However, among the previously re-
ported Rack1 molecular partners, integrin b subunit (Lili-
ental and Chang, 1998) also displayed preference for an
incomplete Rack1 form, prompting the hypothesis that a
regulated Rack1 conformational shift may be involved in
the association between Rack1 and some partners (see
below).
We then attempted to delineate the tract within the
Rack1 C-terminal moiety required for Nef binding by
creating deletion variants of the initial Rack1(WD5–7)
lacking one or two WD repeats and comparing their
ability to activate the yeast system as Gal4–A fusions in
crosses with Gal4–DB–Nef. Results indicated a general
reduction of reporter activation with respect to the refer-
ence construct, which was more dramatic (to near back-
ground levels) with deletions affecting the sixth WD40.
Considering that the sixth WD40 contributes to both the
fifth and the sixth Rack1 propeller blades, a conservative
interpretation of these data may be that residues within
Rack1 blades 5–6 seem particularly important for Nef
binding.
Next we looked for Nef regions important for the in-
teraction (Fig. 2). A collection of terminal deletion vari-
ants, plus a triple point mutant bearing Ala substitutions
at prolines 72-75-78 which are crucial for Nef polyproline
helix-II interaction with SH3 domains [Saksela et al.,
1995; mutant (Pxx)4-], was analyzed. Results showed that
Rack1 binding tolerated deletion of the C-terminal Nef
portion including the internal solvent-exposed loop and
the C-terminal b strand (Grzesiek et al., 1996; Lee et al.,
996), whereas lesions of the N-terminal unstructured
ract and of the central structural core (Grzesiek et al.,
996; Lee et al., 1996) abolished the interaction. How-
ver, an intact polyproline tract was not required for
ef–Rack1 association.
It is important to stress that a sample of the Y2HS Nef
nd Rack1 deletion variants described above was
hecked by Western blot analysis of total yeast protein.
he analysis confirmed that fusions were expressed at
imilar levels (data not shown); therefore, the two-hybrid
eadout reflects bona fide interactions, not variations in
eletion protein stability in yeast cells.
Rat Rack1 was isolated by interaction cloning as an
ctivated C kinase binding protein, hence the name (Ron
t al., 1994). Like other PKC intracellular receptors, it is
hought to mediate the relocalization of activated PKCs.
ince Nef is a substrate for PKC, a relevant question was
hether the Rack1–Nef interaction can influence Nef
odification by PKC. To check this point Rack1 was
ranslated in vitro and mixed with bacterial 6His-taggedef. The Nef–Rack1 complex as eluted from a gel filtra-
ion column, or Nef alone as a control, was exposed to
urified a-g C kinases in a reaction mixture containing
a21, phosphatydilserine, and diglycerides to activate
he enzyme, and [g-32P]ATP. Subsequently, Nef was re-
overed by nickel chelation chromatography under de-
aturing conditions, and washed beads were counted for
adioactivity. Results showed that, under the adopted
onditions, Nef labeling by PKCs was almost doubled by
he presence of Rack1 (Fig. 4A). A comparable result was
btained when Nef copurification with Rack1 by gel fil-
ration was omitted, and Nef was instead mixed in the
ssay with either GST-Rack1(WD5–7) or control Gst: only
he C-terminal Rack1 fusion stimulated Nef phosphory-
ation by PKC (Fig. 4A). Regardless of Rack1 presence,
ef was labeled mostly on serines, as evidenced by
estern blot analysis of the purified Nef with monoclonal
ntibodies specific to phosphoamino acids (Fig. 4B). This
utcome was interesting, since it suggests that Nef and
KCs do not compete for the same binding site(s) on
ack1, although the principal PKC binding site maps
ithin Rack1 WD6 (Ron and Mochly-Rosen, 1995), that is,
n a Rack1 tract which may participate in Nef binding,
ccording to our data. Rather, Rack1 seems to facilitate
ef modification by C kinases.
Nef is targeted to the cytosolic face of cell membranes
y N-terminal myristoylation and the N-terminal unstruc-
ured domain, in particular to rafts (Wang et al., 2000),
lthough a fraction of the protein can be isolated from
ells in soluble form, possibly due to a switch in myristic
xposure. Membrane-bound Nef is detected by immuno-
luorescence (IF) analysis in part on the plasma and
rans-Golgi network membranes, coherently with its
unction in endocytosis (Foti et al., 1997). Rack1 has in
turn been shown to partition between the cytosol and
membrane/cytoskeleton (Chang et al., 1998; Geijsen et
al., 1999; Liliental and Chang, 1998; Ron et al., 1999;
Yarwood et al., 1999). To compare Nef and Rack1 sub-
cellular localization in cells transiently expressing the
viral protein, we investigated it by cell fractionation and
IF. 293-HEK cells were dounced in hypotonic buffer and
nuclei were sedimented at low gravity (600g). Cell mem-
branes were then pelleted by high-speed centrifugation
(100,000g), and the nuclear, microsomal, and cytosolic
fractions were analyzed in Western blot with an anti-
Rack1 Mab. Cells transfected to express Nef were sub-
jected to the same procedure in parallel (Fig. 5). Most of
the Rack1 detected was associated to membranes, with
a minor fraction in the cytosolic extract. This distribution
was unchanged in Nef-expressing cells, where the viral
protein exhibited a similar fractionation profile (a major
fraction with membranes, a minor fraction soluble) in
accord with many previous reports. Also, preexposure of
cells to a PKC agonist [100 ng/ml phorbol myristate
acetate (PMA) for 4 h] did not dramatically alter the
fractionation profile of either protein. The absence of
p
e KC-pos
P anti-ph
12 GALLINA, ROSSI, AND MILANESIPMA effects on Nef subcellular localization confirms
previous reports (Coates et al., 1997; Luo et al., 1997).
IF analysis revealed Rack1 on peripheral and intracel-
lular membrane locations, coherent with the protein be-
ing on plasma and pericentrosomal membranes. Rack1
FIG. 4. Influence of Rack1 on PKCa-g phosphorylation of Nef. (A)
resence/absence of PKC, in vitro translated Rack1 (Nef–Rack1 complex
xperiments are reported, expressed as a percentage of labeling in the P
KC-modified Nef. Anti-PSer, MAb anti-phosphoserine; anti-PThr, MAb
FIG. 5. Rack1 is both soluble and membrane associated. Subcellular
fractionation analysis of HEK-293 human cells was performed. Cells,
either untransfected or Nef-transfected, were dounced in hypotonic
buffer and nuclei were sedimented at low gravity (600g). Cell mem-
branes were then pelleted by high-speed centrifugation (100,000g), and
the nuclear pellet was washed with buffered 1% Triton X-100 and
centrifuged again. The nuclear (P1, washed nuclei), microsomal (P100,
high-speed pellet resolubilized in the nuclear wash), and cytosolic
(S100, high-speed supernatant) fractions were analyzed by Western
blot with an anti-Rack1 Mab or anti-Nef MAb. PMA, cells preexposed to
100 ng/ml phorbol myristate acetate for 4 h.signal was found to colocalize in part with that of clathrin,
the essential constituent of plasma membrane-coated
pits and the TGN vesicle coat, which in turn colocalizes
in part with transfected Nef. Both Nef and Rack1 colo-
calization with clathrin were incomplete, with an appar-
ent variability from cell to cell (Fig. 6 is an example of
substantial colocalization). Altogether, data from cell
fractionation and IF suggest that Rack1 is in part local-
ized on intracellular membranes, at sites partially coin-
ciding with Nef-positive compartments.
The observations reported above might be relevant
with respect to Nef subcellular targeting, to its interac-
tion with PKCs as a substrate, and potentially to its
functional interplay with Src kinases and the endocytic
apparatus. In summary, we have found that Rack1 is a
molecular partner for Nef in both ths and cell-free as-
says. We also found that the Rack1 is, like Nef, in equi-
librium between a cytosolic and membrane-bound state
and that it partially colocalizes with the viral protein on
the intracellular side of membranes. The interaction is
not stable to coimmunoprecipitation (data not shown), a
feature shared with many of the proposed Nef–cell pro-
tein partnerships (e.g., interactions with AP-1 and AP-2
adaptins and kinases of the Src family). Notably, Rack1
binant Nef was incubated with [g-32P]ATP plus PKC cofactors in the
l filtration), GST–Rack1(WD5–7), or GST. The results of three independent
itive sample. (B) Western blot analysis of target amino acid preference in
osphothreomine; anti-PTyr, Mab anti-phosphotyrosine.Recom
from geenhances Nef phosphorylation by PKCs in vitro.
A b propeller fold, which creates two extended lateral
u
p
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13Rack1 BINDS HIV-1 Nefsurfaces and a number of grooves between the blades,
is ideally suited to proteins establishing multiple or dy-
namic contacts, as demonstrated in detail for the b-sub-
nits of heterotrimeric G-proteins, and, among non-WD40
ropellers, the seven-bladed head of the clathrin heavy
hain (ter Haar et al., 1998). It is interesting to recall that
Nef has been proposed to exhibit partial homology to
G-proteins (Ratner and Niederman, 1995), a hypothesis
that subsequent crystallografic and NMR analysis of Nef
molecule failed to confirm. Nonetheless, Nef turns out to
interact with a G b-like protein. Our interaction mapping
analysis suggests that Nef binds the Rack1 propeller in
the fifth groove region, at a site close to a tract important
FIG. 6. Immunofluorescence analysis of Rack1 and Nef subcellular d
paraformaldehyde in PHEM buffer and processed for immunofluoresc
anti-clathrin antiserum. (C, D) Untransfected cells incubated with anti-
the washings the coverslips were stained with TRITC anti-mouse (pan
medium (Molecular Probes), and observed under a Zeiss epifluores
Fluoresceine channel (clathrin). (B, D) Rhodamine channel (Nef or Racfor PKC binding, according to previous reports. The Nef
binding site should not overlap the PKC binding site,however, since Nef and PKC do not compete for Rack1
binding according to the phosphorylation assay. The
Rack1 binding region of PKCs falls within the type I
fold-C2 domain of “classical” isozymes (Rotenberg and
Sun, 1998). Accordingly, other proteins containing a C2
domain–namely, sinaptotagmin I and phospholipase
C-gamma1—have been shown to bind Rack1 as well
(Disatnik et al., 1994; Mochly-Rosen et al., 1992). On such
a basis, theta C kinase, a type II C2 (“novel”) C kinase
which has been implicated as a Nef partner, conversely
is not expected to bind to Rack1, although the theta
isozyme partially colocalizes cytologically with Rack1 in
activated lymphocytes (Wang et al., 1999).
ion in HEK-293 cells. Cells grown on glass coverslips were fixed in 4%
taining. (A, B) Nef-transfected cells incubated with anti-Nef MAb and
Ab and anti-clathrin goat antiserum as the primary antibodies. After
s FITC anti-goat secondary antibodies, mounted in ProLong antifade
microscope connected to a charged coupled camera device. (A, C)
pectively).istribut
ence s
Rack1 M
Ig) pluRack1 fold propensity to protein–protein contacts has
recently found a strong confirmation in reports identify-
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14 GALLINA, ROSSI, AND MILANESIing, by interaction cloning, distinct Rack1 partners: inte-
grin b subunit (Liliental and Chang, 1998), c-Src (Chang
et al., 1998), the constant (b-) chain of macrophage col-
ny-stimulating factor (GM-CSF), interleukin-3 (IL-3) and
nterleukin-5 (IL-5) receptors (Geijsen et al., 1999), and
AMP-specific phosphodiesterase PDE4D5 isoform
Yarwood et al., 1999). PDE4D5 enzyme exhibits the prop-
rties of a very strong interactor for both soluble and
embrane-bound Rack1. Integrin b, on the contrary,
eems to interact only upon cell treatment with PMA.
-Src and other Src family members, like Lck and Yes,
re bound through their N-terminal SH2 domain, and
ack1 binding exerts an inhibitory effect, maybe locking
he kinases in the basal inactive fold (Chang et al., 1998).
M-CSF/IL-3/IL-5 receptor b-chain, finally, seems to be
tably associated to Rack1, while upon PMA stimulation
KC-b joins to the complex. Based on the dependence
on PMA activation, then, Rack1 partners seem to fall into
two classes: those requiring a PMA-induced conforma-
tional shift (in the partner, e.g., PKC, and possibly in
Rack1, in the case of integrin b) and those binding Rack1
onstitutively, such as PDE4D5, Src-like proteins, cyto-
ine receptor b-chain, and Nef. Nef, however, exhibits a
preference for a N-terminally truncated Rack1 in ths, so
that in the Nef–Rack1 association a role for a conforma-
tional switch in the WD40 protein cannot be dismissed.
No obvious Rack1-binding motif is shared by Nef and the
growing list of Rack1 partners (data not shown).
In addition, Rack1 turned out to bind in vitro, in a
lipid-independent manner, a subset of pleckstrin-homol-
ogy (PH) domains, among which are spectrin and dy-
namin-1 PH (Rodriguez et al., 1999). The latter is a par-
ticularly intriguing partner, as dynamin is a known PKC
target as well as a key player in endocytosis.
The above notions set the framework for a functional
interpretation of our findings. Rack1, in view of its sub-
cellular localization on membranes shown here in adher-
ent human cells, may function as a Nef membrane dock-
ing site. Moreover, in vitro phosphorylation data demon-
strate that the Nef–Rack1 interaction can favor Nef
contacts with activated C kinases of the alpha-gamma
isozyme classes, ending up in the kind of viral protein
phosphorylation which has been demonstrated to en-
hance its CD4-downregulation activity (Luo et al., 1997).
In addition, structural and biochemical evidence makes
Rack1 a strong candidate as an adaptor akin to AKAPs,
spatially coordinating the action of multiple signal trans-
duction elements—receptors, kinases, cytoskeletal
components, and possibly endocytic proteins. An entic-
ing hypothesis is that Rack1 may be involved in cluster-
ing of Nef with Src-like kinases, the most obvious can-
didate being the CD4-associated Lck protein. Lck has
been reported to bind Nef via both SH2 and SH3 do-
mains (Dutarte et al., 1998) and to be displaced from CD4
cytoplasmic domain upon Nef-induced CD4 endocytosis
(Kim et al., 1999; Salghetti et al., 1995) on one hand; onthe other. Src-like proteins associated to the same Rack1
tract—WD40 repeats 5–7—that according to our data
binds Nef. It will be important, then, to ascertain whether
Nef can form a ternary complex with Rack1 and Src-like
proteins or whether it displaces the kinase with a pos-
sibly activating effect.
Another possibility, not mutually exclusive, is that
Rack1 may be involved in the clustering of effector/
regulatory proteins of the endocytic pathway, among
which modular molecules including C2 domains (e.g., in
the already mentioned sinaptotagmins) linked to other
protein–protein interaction modules (PH, SH3, EH,
ENTH) recur. Nef’s ability to contact such dynamic as-
semblages would explain the still-elusive Nef effects,
such as the raising of coated pits number (Foti et al.,
1997) and the accumulation of endosomes and lyso-
somes (Sanfridson et al., 1997), facts that do not fit
models describing Nef merely as an adapter for endo-
cytic coat proteins.
Finally, the biological relevance of the Rack1–PKCs
interaction has been demonstrated in part by the use of
peptides mimicking the binding tracts, which inhibit
downstream events like PKC-mediated insulin-induced
maturation of Xenopus oocytes (Mochly-Rosen and Kau-
var, 1998). A similar approach promises to offer further
insights into how Rack1 is involved in Nef functions, and,
more prospectively, to define the potential of peptidomi-
metic compounds blocking Rack1 function as anti-Nef
drugs.
MATERIALS AND METHODS
Cells and antibodies. Human embryonic kidney-293
cells were maintained in Dulbecco’s MEM Glutamax
(Gibco), 10% fetal bovine serum, and antibiotics at 37°C.
Transfections were performed according to the calcium
phosphate method, and cells were processed 48 h post-
transfection.
HIV-1 Nef and human/rat Rack1 proteins were de-
tected with monoclonal antibody (MAb) 2001 anti-Nef
(Chemicon) and with MAb R20620 (IgM) anti-Rack1 C-
terminus (Transduction Laboratories), respectively. Anti-
clathrin goat antiserum and anti-phosphoamino acids
MAbs were from Sigma. HRP-conjugated anti-rabbit and
anti-mouse antibodies were obtained from Bio-Rad; HRP-
conjugated anti-mouse IgM antibodies were from
Chemicon; fluorescein isothiocyanate (FITC)-conjugated
anti-mouse antibodies and tetramethylrhodamine
(TRITC)-conjugated anti-goat antibodies were from
Sigma.
Plasmid constructions. The HIV-1 (BH10 strain) nef
gene constructs used in this study to express full-length
Nef in eukaryotic or prokaryotic cells have been previ-
ously described (Rossi et al., 1997). pMTNef plasmid
drives wt Nef expression from the strong adenovirus
MLP promoter; pTRC–Nef expresses inducibly a hexa-
r
a
N
t
f
f
(
b
t
p
p
t
f
p
l
p
e
p
p
s
t
p
P
t
v
(
c
a
p
t
p
7
a
S
a
s
l
s
s
(
s
w
b
G
olumn
t sequen
15Rack1 BINDS HIV-1 Nefhistidine-Xpress epitope-tagged Nef in Escherichia coli.
The control plasmid pTRC-preS expresses the hepatitis
B virus preS domain coding sequence, bearing the same
N-terminal tag as bacterial Nef.
Similarly, yeast ths Nef derivatives have been de-
scribed (Rossi et al., 1997), with the exception of con-
struct pGBT9–Nef(Pxx)4
2. This was obtained by PCR-di-
ected mutagenesis to replace wt Nef prolines 72, 75,
nd 78 with alanines. The mutagenic primer pairs Nef59–
efMut anti and NefMut–Nef39anti (Table 1) were used
o separately amplify the 59 and 39 moieties of Nef cDNA
rom the cloned provirus DNA. In these and other ampli-
ications cited hereafter, the high fidelity Pfu polymerase
Stratagene) was used. The first amplification products,
earing the mutated sequence at one end, were merged
hrough a second amplification round using the external
rimers. The final mutated Nef cDNA was cloned into
BlueScript SK1, sequenced, and transferred into the
hs vector pGBT9 (Clontech) downstream from, and in
rame with the Gal4–DB coding region.
pBS–Rack1 plasmid was created by cloning into
BlueScriptSK1 vector the sequence encoding full-
ength rat Rack1, amplification-excised from plasmid
DM89 (a kind gift from Daria Mochly-Rosen) with prim-
rs Rack 59 w/Rack1 and Rack 39endstopanti (Table 1).
Gex–Rack1 was obtained by subcloning one of the
GAD GH–Rack1 clones originally isolated with ths
creening (see Results and Discussion, and below) into
he EcoRI–XhoI sites in pGex–4T-3 vector. The construct
Gex–Plk1Cter, used as a control in this work, bears the
olo-like kinase 1 (Plk1) C-terminal domain cloned into
he pGex–4T-3 expression site and was described pre-
iously (Gallina et al., 1999).
T
Amplific
Primer
Nef59 TCGCCGGAATTCGGTG
Nef39 anti ACGCCTCTGCAGTCAG
NefMut ACAGCTCAGGTAGCTT
NefMut anti CATTGCTCTTAAAGCTA
Rack 59wo/R1 TCTGACGAATTCACCG
Rack 59 w/R1 GCAACAGAATTCGCCA
Rack 39endstopanti TGTCATGTCGACTTAG
Rack 39WD4-Stopanti CTTGCAGTCGACTCAA
Rack 59 WD5-Nsense AAGGTGGAATTCCTGG
Rack 39WD6-Stopanti GATCTTGTCGACTCAG
Rack 39WD5D6 TTCATTGGGATCCCAC
Rack 59WD7D6 ATCTGAGATCTGGAGG
Rack 39WD5-Stopanti CTTGCCGTCGACTCAA
Rack 69WD6-Nsense ATGCTGGAATTCCTCA
a Underbar, restriction sites introduced for cloning (names in the c
ermination; boldface italics: residues mutated with respect to naturalThe Rack1 deletion derivatives analyzed in ths crosses
Fig. 2) were created using combinations of the amplifi-ation primers reported in Table 1, restricted with EcoRI
nd SalI, and cloned accordingly into yeast vector
ACT2. For generating the internal deletion insert WD5/7,
he tract coding for the sixth Rack1 WD40 repeat was
recisely removed by separately amplifying WD40 5 and
coding sequences and then fusing them through a BglII
nd BamHI site engineered in either product.
Yeast two-hybrid system. All ths experiments exploited
accharomyces cerevisiae HF7c strain, carrying HIS3
nd lacZ markers under the control of Gal4-responsive
equences. Yeast transformation, selection, filter, and, in
iquid, b-galactosidase assays were performed as de-
scribed previously (Gallina et al., 1999).
Recombinant proteins. E. coli DH5-a cells harboring
pGEX–Rack1, pGex–Plk1Cter, or the void vector were
induced with 1 mM isopropyl-b-D-thiogalctopyranoside
for 3 h, and the corresponding glutathione S-transferase
proteins were purified from bacterial lysates by gluta-
thione–Sepharose (Pharmacia) chromatography, accord-
ing to the manufacturer’s instructions. GST fusions were
eluted with 25 mM reduced glutathion in 25 mM Tris–
HCl, pH 7.5, and dyalized against PBS. Hexahistidine-
tagged Nef (His–Nef) and His–preS purification has been
described (Rossi et al., 1997).
A L-[35S]methionine-labeled Rack1 protein was synthe-
ized in vitro by programming the TNT-T7 coupled tran-
cription–translation rabbit reticulocyte lysate system
Promega) with pBS–Rack1 plasmid (37°C/45 min). Sub-
equently, the translation mixture was complemented
ith nonradioactive 1 mM L-methionine and further incu-
ated for 45 min.
In vitro binding assays. For pull-down assays, purified
ST–Rack1 or the GST controls (5 mg each) were read-
rimersa
nce Restriction site
TGGTCAAAAAGTAGT EcoRI
CTTGAAGTACTCCGG SalI
GCAATGACTTACAAGGCAG —
AGCTGTGACTGGAAAACC —
ATGACCCTTCGTGGGAC EcoRI
GAGCAAATGACCCTTCG EcoRI
ACCAATAGTCACCTG SalI
CACCTTGACCAGCTTGTC SalI
TGCAAGCTAAAGACC EcoRI
GATCTTGATACTGGGGC SalI
AGCCTGGCCATCCTTGCC BamHI
ATCATGGTAGATGAAC Bgl2
CAGCATAGCCTGGCCATCC SalI
GGCAAGCACCTTTACAC EcoRI
at right); boldface, stop codons (antisense) for premature translation
ces.ABLE 1
ation P
Seque
GCAAG
CAGTT
TAAGA
CCTG
AGCAA
TGACC
CGGGT
TTCCA
CTAAC
TCCCA
AGCAT
GCAAG
TCCCA
ATGAAsorbed onto glutathione–Sepharose resin and incubated
with His–Nef or His–preS in binding buffer [25 mM
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16 GALLINA, ROSSI, AND MILANESIHepes, pH 7.4, 50 mM NaCl, 2.5 mM CaCl2, 1 mM MgCl2,
.1% Triton, 1% BSA. Complete protease inhibitors
Roche)] for 1 h at 4°C. The resin was washed four times
n the same buffer lacking BSA. Resin-bound complexes
ere boiled in SDS–PAGE sample buffer and the eluted
roteins were resolved in SDS–PAGE (12% acrylamide in
unning gel) and electroblotted to nitrocellulose (Probond
3, Schleicher & Schull). After primary antibody and HRP-
onjugated secondary antibody incubations, signal was
eveloped with SuperSignal Dura (Pierce) enhanced
hemiluminescence substrate.
For gel filtration analysis of the Rack1–Nef interaction,
0 ml of the Rack1 in vitro translation reaction was mixed
with 2 mg of recombinant His–Nef in 100 ml of binding
uffer (without BSA). After 1 h of incubation at 4°C, the
ixture was loaded onto a 15-ml analytical Sephacryl
00 column and the eluted fractions were analyzed by
estern blotting with anti-Nef MAb. The dried blot was
hen exposed to a phosphorimager screen for 24 h.
In vitro phosphorylation experiments. The His–Nef–
Rack1 complex as eluted from gel filtration column (ap-
proximately 50 ng of recombinant Nef) or His–Nef with/
without added GST–Rack1(WD5–7) or GST (50 ng either)
was incubated, with or without 40 mU of PKCa-g (Roche),
at 37°C/30 min in PKC buffer: 20 mM Tris–HCl, pH 7.5, 10
mM MgCl2, 0.5 mM CaCl2, 100 ng/ml phosphatidylserine,
50 pM ATP, 100 mCi/ml [g32P]ATP, 5000 Ci/mmol (Amer-
sham). The reaction was brought to completion by the
addition of 100 mM ATP and further incubation for an-
other 10 min. The reaction was stopped with 1 ml of 6 M
guanidinium–HCl and 100 mM Tris–HCl, pH 8, and 20
ml/reaction of nickel–NTA agarose (Qiagen) beads were
added and shaken end-over-end for 30 min at room
temperature. Beads were washed three times in guani-
dinium buffer and the captured His–Nef radioactivity was
determined by scintillation. Alternatively, beads were
washed one more time with 100 mM Tris–HCl, pH 8, and
boiled in SDS–PAGE sample buffer for Western blot anal-
ysis with anti-phosphoamino acid MAbs.
Cell transfection, fractionation, and IF analysis. 293-
HEK cells were transfected with the standard calcium
phosphate protocol, 2 mg plasmid/3 3 106 cells. For
subcellular fractionations, cells were dounced in ipotonic
buffer and nuclei sedimented at low gravity (600g). Cell
membranes were then pelleted by high-speed centrifu-
gation (100,000g), and the nuclear, microsomal, and cy-
tosolic fractions were analyzed in Western blot with anti-
Rack1 or anti-Nef MAbs. For IF, 1 3 105 cells were
seeded on polylysine-coated glass coverslips. Trans-
fected cells were detached with versene 24 h posttrans-
fection and plated as above. Monolayers were washed
twice with PBS containing 0.9 mM CaCl2 and 0.45 mM
gCl2, prewarmed at 37°C, and fixed in freshly pre-
pared, ice-cold 3% (v/v) paraformaldehyde in PBS for 20
min on ice. After being washed three times with ice-cold
PBS, residual aldehydes were quenched by immersing Feach slide in 150 mM ammonium chloride for 30 min.
Cells were permeabilized by treatment for 30 min with
0.1% (w/v) saponin in PBS and 10% (v/v) FBS. Incubations
with primary antibodies (10 mg/ml) were performed in the
ame buffer for 30 min in a humid chamber at 37°C. After
hree washes, cells were incubated simultaneously with
ITC-anti-goat and TRITC-anti-mouse secondary anti-
odies in the same medium [Supplemented with 0.2
mg/ml, 4,6-diamidino-2-phenylindole as a nuclear coun-
terstain]. After the final washes, the coverslips were
mounted in ProLong antifade medium (Molecular
Probes, Eugene, OR) and examined under a Zeiss epi-
fluorescence microscope connected to a charged-cou-
pled device camera with direct digital image recording.
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